Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117069602B reveals a cleaner rare earth catalytic route for gamma-amino alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115232163B reveals a transition-metal-free NHC catalytic route for silicon-centered chiral compounds, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN111848322B details a novel chiral phosphoric acid resolution method for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN110746278B reveals a mild, non-metal route for 1,3-diketones. Achieve high purity and cost reduction in API manufacturing without precious metal catalysts.
Patent CN114874139A details a green visible-light method for 1-benzyl-3,4-dihydroisoquinoline. Offers cost-effective, scalable pharma intermediate production.
Patent CN113307790B reveals a metal-free oxidative cyclization route for 1,2,4-triazole intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical applications.
Patent CN113307790B reveals a metal-free oxidative cyclization route for quinolyl-triazoles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113773253A reveals a mild AgI-catalyzed route to fully substituted pyrazoles. Discover high-yield synthesis for cost-effective API manufacturing.
Novel graphene oxide catalyzed process for high-purity p-Menthane-3,8-diol. Reduces acid waste and improves cis-isomer selectivity for reliable supply chains.
Patent CN113735867B reveals mild synthesis for antitumor intermediates. Offers high yield and enantioselectivity for cost-effective supply chain solutions.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones with potent anti-tumor activity, offering reliable supply chain solutions.
Patent CN110467555B reveals a chiral phosphoric acid catalyzed route for high-purity axial chiral aryl indoles, offering cost-effective API intermediate manufacturing.
Patent CN113461589B details a novel one-step asymmetric Friedel-Crafts reaction for chiral 2,3-disubstituted indoleamines, offering significant cost reduction in API manufacturing.
Novel chiral phosphoric acid catalyzed synthesis of indoxazinones with high enantioselectivity and mild conditions for anticancer drug development.
Patent CN107936025B details a metal-free NHC catalytic route for high-purity chiral intermediates, offering significant cost reduction in API manufacturing and scalable supply.
Patent CN114160206B reveals a novel chiral copper catalyst for optically active indoles. Achieve >91% ee and substantial cost reduction in API manufacturing with scalable processes.
Patent CN118878452B reveals a mild catalytic route for anti-tumor intermediates. This report analyzes supply chain stability and cost reduction in pharma manufacturing.
Patent CN102153433B details an aerobic oxidative synthesis of N-monosubstituted-alpha-carbonylamides. This method offers significant cost reduction in pharmaceutical intermediate manufacturing via mild, scalable conditions.
Patent CN101245064A details a novel six-step synthesis for berberine hydrochloride, offering high yields and eliminating heavy metal catalysts for cost-effective pharmaceutical intermediate manufacturing.